419 related articles for article (PubMed ID: 10027940)
1. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
Wollesen F; Brattström L; Refsum H; Ueland PM; Berglund L; Berne C
Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940
[TBL] [Abstract][Full Text] [Related]
2. Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate.
Bostom AG; Kronenberg F; Jacques PF; Kuen E; Ritz E; König P; Kraatz G; Lhotta K; Mann JF; Müller GA; Neyer U; Riegel W; Schwenger V; Riegler P; Selhub J
Atherosclerosis; 2001 Nov; 159(1):219-23. PubMed ID: 11689224
[TBL] [Abstract][Full Text] [Related]
3. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
4. Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly.
Lewerin C; Ljungman S; Nilsson-Ehle H
J Intern Med; 2007 Jan; 261(1):65-73. PubMed ID: 17222169
[TBL] [Abstract][Full Text] [Related]
5. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
Ozmen B; Ozmen D; Turgan N; Habif S; Mutaf I; Bayindir O
Ann Clin Lab Sci; 2002; 32(3):279-86. PubMed ID: 12175091
[TBL] [Abstract][Full Text] [Related]
6. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
[TBL] [Abstract][Full Text] [Related]
7. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration.
Arnadottir M; Hultberg B; Nilsson-Ehle P; Thysell H
Scand J Clin Lab Invest; 1996 Feb; 56(1):41-6. PubMed ID: 8850171
[TBL] [Abstract][Full Text] [Related]
8. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study.
El-Khairy L; Ueland PM; Nygård O; Refsum H; Vollset SE
Am J Clin Nutr; 1999 Dec; 70(6):1016-24. PubMed ID: 10584046
[TBL] [Abstract][Full Text] [Related]
9. Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease.
Moat SJ; Bonham JR; Powers HJ
Clin Sci (Lond); 2001 Jan; 100(1):73-9. PubMed ID: 11115421
[TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine levels in patients with type 2 diabetes in a Mediterranean population: relation with nutritional and other factors.
Diakoumopoulou E; Tentolouris N; Kirlaki E; Perrea D; Kitsou E; Psallas M; Doulgerakis D; Katsilambros N
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):109-17. PubMed ID: 15871859
[TBL] [Abstract][Full Text] [Related]
11. Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project.
El-Khairy L; Ueland PM; Refsum H; Graham IM; Vollset SE;
Circulation; 2001 May; 103(21):2544-9. PubMed ID: 11382721
[TBL] [Abstract][Full Text] [Related]
12. Reduced urinary excretion of homocysteine could be the reason of elevated plasma homocysteine in patients with psychiatric illnesses.
Ipcioglu OM; Ozcan O; Gultepe M; Ates A; Basoglu C; Cakir E
Clin Biochem; 2008 Jul; 41(10-11):831-5. PubMed ID: 18457673
[TBL] [Abstract][Full Text] [Related]
13. Physical training decreases total plasma homocysteine and cysteine in middle-aged subjects.
Gaume V; Mougin F; Figard H; Simon-Rigaud ML; N'Guyen UN; Callier J; Kantelip JP; Berthelot A
Ann Nutr Metab; 2005; 49(2):125-31. PubMed ID: 15860911
[TBL] [Abstract][Full Text] [Related]
14. A C677T mutation in the methylenetetrahydrofolate reductase gene modifies serum cysteine in dialysis patients.
Kimura H; Gejyo F; Suzuki S; Takeda T; Miyazaki R; Yoshida H
Am J Kidney Dis; 2000 Nov; 36(5):925-33. PubMed ID: 11054348
[TBL] [Abstract][Full Text] [Related]
15. Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.
Herrmann W; Schorr H; Obeid R; Makowski J; Fowler B; Kuhlmann MK
Clin Chem; 2005 May; 51(5):891-7. PubMed ID: 15774574
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Am J Kidney Dis; 2004 Sep; 44(3):455-65. PubMed ID: 15332218
[TBL] [Abstract][Full Text] [Related]
17. Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance.
Veldman BA; Vervoort G; Blom H; Smits P
Diabet Med; 2005 Mar; 22(3):301-5. PubMed ID: 15717878
[TBL] [Abstract][Full Text] [Related]
18. Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.
Melenovsky V; Stulc T; Kozich V; Grauova B; Krijt J; Wichterle D; Haas T; Malik J; Hradec J; Ceska R
Am Heart J; 2003 Jul; 146(1):110. PubMed ID: 12851616
[TBL] [Abstract][Full Text] [Related]
19. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria.
Stehouwer CD; Gall MA; Hougaard P; Jakobs C; Parving HH
Kidney Int; 1999 Jan; 55(1):308-14. PubMed ID: 9893141
[TBL] [Abstract][Full Text] [Related]
20. Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.
Hovind P; Tarnow L; Rossing P; Teerlink T; Stehouwer CD; Emeis JJ; Parving HH
Am J Kidney Dis; 2001 Dec; 38(6):1376-80. PubMed ID: 11728978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
